Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Dermatologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.JAMA Dermatol. 2015; 151: 1081-1086
- American Cancer Society. Cancer Statistics Center.(Available at:) (Accessed January 2)
- Basal cell carcinoma.Postgrad Med J. 1997; 73: 538-542
- Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5.J Am Acad Dermatol. 1996; 35: 1012-1013
- Basal-cell carcinoma incidence and associated risk factors in U.S. women and men.Am J Epidemiol. 2013; 178: 890-897
- Skin cancer and ultraviolet-B radiation under the Antarctic ozone hole: southern Chile, 1987-2000.Photodermatol Photoimmunol Photomed. 2002; 18: 294-302
- Skin cancer trends among Asians living in Singapore from 1968 to 2006.J Am Acad Dermatol. 2009; 61: 426-432
- Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study.Int J Cancer. 2007; 121: 2105-2108
- Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985.Med J Aust. 2006; 184: 6-10
- A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin.Cancer Epidemiol. 2013; 37: 534-543
- Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study.Br J Cancer. 2006; 94: 743-751
- Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study.Am J Epidemiol. 1999; 150: 459-468
- Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients.J R Soc Med. 1997; 90: 371-374
- Pigmentary and cutaneous risk factors for non-melanocytic skin cancer--a case-control study.Int J Cancer. 1991; 48: 650-662
- Risk factors for basal cell carcinoma: a case-control study.Rev Saude Publica. 1995; 29: 27-37
- Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma.Arch Dermatol. 1995; 131: 157-163
- Early-onset basal cell carcinoma and indoor tanning: a population-based study.Pediatrics. 2014; 134: e4-e12
- Epidemiological evidence of carcinogenicity of sunbed use and of efficacy of preventive measures.J Eur Acad Dermatol Venereol. 2019; 33: 57-62
- Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis.Bmj. 2012; 345: e5909
- Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.J Natl Cancer Inst. 1996; 88: 1848-1853
- Solid cancer incidence in atomic bomb survivors: 1958-1998.Radiat Res. 2007; 168: 1-64
- Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group.Arch Dermatol. 2000; 136: 1007-1011
- Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study.J Natl Cancer Inst. 2012; 104: 1240-1250
- Incidence of skin cancer after renal transplantation in The Netherlands.Transplantation. 1990; 49: 506-509
- The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.J Am Acad Dermatol. 2012; 66: 553-562
- The many faces of basal-cell carcinoma.J Dermatol Surg Oncol. 1978; 4: 23-28
- Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.Arch Dermatol. 1997; 133: 593-596
- Variations of basal cell carcinomas according to gender, age, location and histopathological subtype.Br J Dermatol. 2002; 147: 41-47
- NCCN. Basal Cell Skin Cancer (Version 1.2022).(Available at:) (Accessed January 8, 2022)
- AJCC cancer staging manual.8th edition. Springer Publishing, New York2017
- Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.J Am Acad Dermatol. 2021; 85: 582-587
- Metastatic basal cell carcinoma: Report of five cases and review of 170 cases in the literature.J Am Acad Dermatol. 1984; 10: 1043-1060
- Metastatic basal cell carcinoma: Report of twelve cases with a review of the literature.J Am Acad Dermatol. 1991; 24: 715-719
- Metastatic basal cell carcinoma. Report of five cases. Article.Cancer. 1994; 73: 328-335
- Update on Metastatic Basal Cell Carcinoma: A Summary of Published Cases From 1981 Through 2011.JAMA Dermatol. 2013; 149: 615-616
- Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease.Eur J Cancer. 2014; 50: 774-783
- Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter.J Am Acad Dermatol. 2020; 83: 832-838
- The diagnostic accuracy of dermoscopy for basal cell carcinoma: A systematic review and meta-analysis.J Am Acad Dermatol. 2019; 80: 1380-1388
- Introduction to Confocal Microscopy.J Invest Dermatol. 2012; 132: 1-5
- A meta-analysis of reflectance confocal microscopy for the diagnosis of malignant skin tumours.J Eur Acad Dermatol Venereol. 2016; 30: 1295-1302
- Biopsy outperforms reflectance confocal microscopy in diagnosing and subtyping basal cell carcinoma: results and experiences from a randomized controlled multicentre trial.Br J Dermatol. 2021; 184: 663-671
- The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study.Br J Dermatol. 2015; 173: 428-435
- Machine-learning classification of non-melanoma skin cancers from image features obtained by optical coherence tomography.Skin Res Technol. 2008; 14: 364-369
- Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists.Dermatol Surg. 2009; 35: 965-972
- Imaging Technologies for Pre-surgical Margin Assessment of Basal Cell Carcinoma.J Am Acad Dermatol. 2021; https://doi.org/10.1016/j.jaad.2021.11.010
- Treatment of basal cell carcinoma with curettage alone.J Am Acad Dermatol. 2006; 54: 1039-1045
- A Systematic Review of Treatment Modalities for Primary Basal Cell Carcinomas.Arch Dermatol. 1999; 135: 1177-1183
- Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.Dermatol Surg. 2013; 39: 719-725
- Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.J Am Acad Dermatol. 2007; 56: 91-95
- Curettage-electrodesiccation treatment of basal cell carcinomas.Arch Dermatol. 1977; 113: 439-443
- Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.J Plast Reconstr Aesthet Surg. 2017; 70: 1738-1745
- Surgical margins for basal cell carcinoma.Arch Dermatol. 1987; 123: 340-344
- Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.Eur J Cancer. 2014; 50: 3011-3020
- Recurrence rate of basal cell carcinoma in patients submitted to skin flaps or grafts.An Bras Dermatol. 2019; 94: 442-445
- Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.Cutis. 2010; 85: 318-324
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.Br J Dermatol. 2005; 152: 939-947
- Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.Lancet Oncol. 2013; 14: 647-654
- Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.J Invest Dermatol. 2016; 136: 1568-1574
- Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial.Br J Dermatol. 2001; 144: 832-840
- Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial.Eur J Dermatol. 2008; 18: 547-553
- Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy.Clin Radiol. 1986; 37: 33-34
- Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis.Photodermatol Photoimmunol Photomed. 2015; 31: 44-53
- Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up.J Dermatol Surg Oncol. 1989; 15: 315-328
- Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.J Dermatol Surg Oncol. 1989; 15: 424-431
- Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study.Br J Cancer. 1997; 76: 100-106
- Bath-Hextall FJ. Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments.Br J Dermatol. 2021; 185: 499-511
- Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline.Pract Radiat Oncol. 2020; 10: 8-20
- Basal cell carcinomas: attack of the hedgehog.Nat Rev Cancer. 2008; 8: 743-754
- High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature.Chemotherapy. 2020; 65: 2-10
- Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma.J Clin Oncol. 2014; 32: 745-751
- Platinum-based cytotoxic therapy in basal cell carcinoma--a review of the literature.Acta Oncol. 1996; 35: 677-682
- Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.Lancet. 1999; 354: 723-729
- Sun protection for preventing basal cell and squamous cell skin cancers.Cochrane Database Syst Rev. 2016; 7: Cd011161
- A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.N Engl J Med. 2015; 373: 1618-1626
- History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.J Natl Cancer Inst. 2017; 109
- Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.JAMA Dermatol. 2015; 151: 382-388
- Risk of subsequent non-melanoma skin cancer in a cohort of patients with primary basal cell carcinoma.J Eur Acad Dermatol Venereol. 2004; 18: 514-515
Article info
Publication history
Published online: October 27, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
